0001493152-16-011142.txt : 20160628 0001493152-16-011142.hdr.sgml : 20160628 20160628212030 ACCESSION NUMBER: 0001493152-16-011142 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160624 FILED AS OF DATE: 20160628 DATE AS OF CHANGE: 20160628 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TearLab Corp CENTRAL INDEX KEY: 0001299139 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 593434771 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9980 HUENNEKENS ST. STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-794-1400 MAIL ADDRESS: STREET 1: 9980 HUENNEKENS ST. STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: OccuLogix, Inc. DATE OF NAME CHANGE: 20040730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VAMVAKAS ELIAS CENTRAL INDEX KEY: 0001061865 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51030 FILM NUMBER: 161737187 MAIL ADDRESS: STREET 1: 5280 SOLAR DRIVE STREET 2: SUITE 100 CITY: MISSISSAUGA STATE: A6 ZIP: L4W 5M8 4 1 form4.xml X0306 4 2016-06-24 0 0001299139 TearLab Corp TEAR 0001061865 VAMVAKAS ELIAS 9980 HUENNEKENS ST., STE 100 SAN DIEGO, CA 92121 1 1 0 0 Chairman Stock Option (right to buy) 0.69 2016-06-24 4 A 0 50000 0.00 A 2026-06-24 Common Stock 50000 50000 D One third (1/3rd) of the shares subject to the option shall vest and become exercisable on the one (1) year anniversary of June 24, 2016 (the "Vesting Commencement Date") and, thereafter, one third (1/3rd) of the shares subject to the option shall vest and become exercisable on the second (2nd) anniversary of the Vesting Commencement Date, and one third (1/3rd) of the shares subject to the option shall vest and become exercisable on the third (3rd) anniversary of the Vesting Commencement Date, subject to the Reporting Person continuing to be a service provider on each such date. /s/ Wes Brazell, as Attorney-in-Fact 2016-06-28 EX-24 2 ex24.htm

POWER OF ATTORNEY

The undersigned, as a Section 16 reporting person of TearLab Corporation. (the “Company”), hereby constitutes and appoints Wes Brazell, Mike Wiedemer, Dan Horwood and Ben Capps as the undersigned’s true and lawful attorneys-in-fact to:

	1.	complete and execute Forms 3, 4 and 5 and other forms and all amendments thereto as such attorney-in-fact shall in his or her discretion determine to be required or advisable pursuant to Section 16 of the Securities Exchange Act of 1934 (as amended) and the rules and regulations promulgated thereunder, or any successor laws and regulations, as a consequence of the undersigned’s ownership, acquisition or disposition of securities of the Company; and

	2.	do all acts necessary in order to file such forms with the Securities and Exchange Commission, any securities exchange or national association, the Company and such other person or agency as the attorney-in-fact shall deem appropriate.

The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agents shall do or cause to be done by virtue hereof. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934 (as amended).

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 24th day of June, 2016.

	Signature:	/s/ Elias Vamvakas

	Print Name:	Elias Vamvakas